(Total Views: 93)
Posted On: 11/01/2022 2:31:21 PM
Post# of 40431
$NBIO News November 01, 2022
Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394
"This issuance strengthens our growing IP portfolio in our brain cancer treatment using Pritumumab, a unique natural antibody that crosses the blood brain barrier," said Sean Carrick, CEO of Nascent.
https://finance.yahoo.com/news/nascent-biotec...00713.html
$ACRZF $CLABD $CTTQF $FTROF $IOIOF $LOWLF $OPTHF $WKULF $SDPNF $TSLLF
Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394
"This issuance strengthens our growing IP portfolio in our brain cancer treatment using Pritumumab, a unique natural antibody that crosses the blood brain barrier," said Sean Carrick, CEO of Nascent.
https://finance.yahoo.com/news/nascent-biotec...00713.html
$ACRZF $CLABD $CTTQF $FTROF $IOIOF $LOWLF $OPTHF $WKULF $SDPNF $TSLLF
(0)
(0)
